SIMVASTATIN Recall D-0523-2023
Description: Simvastatin Tablets, USP, 80 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-9429-9
SIMVASTATIN Recall D-0523-2023 Information
Status | Ongoing |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-0523-2023 |
Event ID | 91952 |
Brand | SIMVASTATIN |
Generic Name | SIMVASTATIN |
Manufacturer | SIMVASTATIN |
Active Substance | SIMVASTATIN |
Drug Route | ORAL |
Distribution | USA Nationwide |
Quantity | 57 Bottles |
Recall Reason | cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. |
Drug Classification | Class II |
Drug Code Info | 20230412 |
Product NDC | 68788-9429 68788-9747 68788-9869 |
Product NUI | N0000175589 N0000000121 |
Pharma Class (EPC) | HMG-CoA Reductase Inhibitor [EPC] |
Recall Initiation Date | 20230323 |
Report Date | 20230412 |
Classification Date | 20230406 |
Address | 1250 N Lakeview Ave Ste O Anaheim, CA 92807-1801 United States |
Recalling Firm | Preferred Pharmaceuticals, Inc. |
Initial Notification | Letter |
Unique Ingredient Identifier | AGG2FN16EV |
Drug Application Number | ANDA078155 |
Structured Product Labeling (SPL ID) | a6a377c0-6795-4d61-8c65-678cfdf04aaf |
Structured Product Labeling (SPL Set ID) | 7442f35f-74e8-4c35-9666-190a3baad549 |
Similar To |